Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0847 | 0.0847 |
Loa Loa (eye worm) | hypothetical protein | 0.0191 | 0.612 | 0.612 |
Onchocerca volvulus | 0.0284 | 0.9442 | 1 | |
Echinococcus multilocularis | jun protein | 0.0196 | 0.6311 | 0.6311 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0395 | 1 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0847 | 0.0847 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.6451 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0395 | 0.0395 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0395 | 1 |
Echinococcus multilocularis | geminin | 0.02 | 0.6451 | 0.6451 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0395 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0395 | 1 |
Mycobacterium tuberculosis | Probable isocitrate dehydrogenase [NADP] Icd1 (oxalosuccinate decarboxylase) (IDH) (NADP+-specific ICDH) (IDP) | 0.0019 | 0 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0847 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.02 | 0.6451 | 1 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0847 | 0.1313 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0847 | 0.5 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription factor | 0.0196 | 0.6311 | 0.6311 |
Schistosoma mansoni | jun-related protein | 0.016 | 0.5004 | 0.7757 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0395 | 1 |
Echinococcus granulosus | geminin | 0.02 | 0.6451 | 0.6451 |
Brugia malayi | hypothetical protein | 0.003 | 0.0395 | 0.0395 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0141 | 0.4349 | 0.4349 |
Echinococcus granulosus | zinc finger transcription factor gli2 | 0.03 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0141 | 0.4349 | 0.4349 |
Brugia malayi | hypothetical protein | 0.0154 | 0.4813 | 0.4813 |
Loa Loa (eye worm) | zinc finger protein | 0.03 | 1 | 1 |
Brugia malayi | Pax transcription factor protein 2 | 0.0284 | 0.9442 | 0.9442 |
Schistosoma mansoni | hypothetical protein | 0.016 | 0.5004 | 0.7757 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0847 | 0.1313 |
Brugia malayi | bZIP transcription factor family protein | 0.0196 | 0.6311 | 0.6311 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0395 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0847 | 0.0847 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0141 | 0.4349 | 0.4349 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0847 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0395 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0395 | 1 |
Loa Loa (eye worm) | pax transcription factor protein 2 | 0.0284 | 0.9442 | 0.9442 |
Echinococcus multilocularis | zinc finger transcription factor gli2 | 0.03 | 1 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription factor | 0.0196 | 0.6311 | 0.6311 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0847 | 0.5 |
Echinococcus granulosus | jun protein | 0.0196 | 0.6311 | 0.6311 |
Brugia malayi | hypothetical protein | 0.0019 | 0.002 | 0.002 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 213 % | MDR-reversing activity in K562/ADM cells at 1 microM concentration of [3H]-VCR (vincristine), activity expressed relative to verapamil. | ChEMBL. | 9207946 |
Activity (functional) | = 213 % | MDR-reversing activity in K562/ADM cells at 1 microM concentration of [3H]-VCR (vincristine), activity expressed relative to verapamil. | ChEMBL. | 9207946 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.